(1) Palacios C and Gonzalez L. Is vitamin D deficiency a major global public health problem? The Journal of steroid biochemistry and molecular biology. (2014) 144: 138-45.
(2) Bachali S, Dasu K, Ramalingam K, and Naidu J. Vitamin D deficiency and insulin resistance in normal and type 2 diabetes subjects. Indian Journal of Clinical Biochemistry. (2013) 28: 74-8.
(3) Sung C-C, Liao M-T, Lu K-C, and Wu C-C. Role of vitamin D in insulin resistance. BioMed Research International. (2012) 2012:
(4) Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition. (2003) 89: 552-72.
(5) Mathieu C, Gysemans C, Giulietti A, and Bouillon R. Vitamin D and diabetes. Diabetologia. (2005) 48: 1247-57.
(6) Berridge MJ. Vitamin D deficiency and diabetes. Biochemical Journal. (2017) 474: 1321-32.
(7) Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, and Haddad PS. Relationship between insulin resistance and plasma vitamin D in adults. Diabetes, metabolic syndrome and obesity: targets and therapy. (2014) 7: 297.
(8) Fondjo LA, Owiredu WK, Sakyi SA, Laing EF, Adotey-Kwofie MA, Antoh EO, and Detoh E. Vitamin D status and its association with insulin resistance among type 2 diabetics: A case-control study in Ghana. PLoS One. (2017) 12: e0175388.
(9) Durmaz ZH, Demir AD, Ozkan T, Kılınç C, Güçkan R, and Meral Tiryaki M. Does vitamin D deficiency lead to insulin resistance in obese individuals. Biomed Res. (2017) 28: 7491-7.
(10) Hoseini SA, Aminorroaya A, Iraj B, and Amini M. The effects of oral vitamin D on insulin resistance in pre-diabetic patients. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. (2013) 18: 47.
(11) Ju SY, Jeong HS, and Kim DH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab. (2014) 99: 1053-63.
(12) Rocha LM, BALDAN DCdS, Souza AL, Chaim EA, Pavin EJ, and Alegre SM. Body composition and metabolic profile in adults with vitamin D deficiency. Revista de Nutrição. (2017) 30: 419-30.
(13) Gulseth HL, Wium C, Angel K, Eriksen EF, and Birkeland KI. Effects of vitamin D supplementation on insulin sensitivity and insulin secretion in subjects with type 2 diabetes and vitamin D deficiency: a randomized controlled trial. Diabetes Care. (2017) 40: 872-8.
(14) DeFronzo RA, Tobin JD, and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology-Endocrinology And Metabolism. (1979) 237: E214.
(15) Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, and Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. The Journal of Clinical Endocrinology & Metabolism. (2000) 85: 2402-10.
(16) Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y-DI, Sands RE, Pei D, Savage PJ, and Bergman RN. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes. (1994) 43: 1114-21.
(17) Singh B and Saxena A. Surrogate markers of insulin resistance: A review. World journal of diabetes. (2010) 1: 36.
(18) Xiang A, Watanabe R, and Buchanan T. HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings. Diabetologia. (2014) 57: 334-8.
(19) Ferrara CM and Goldberg AP. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes care. (2001) 24: 245-9.
(20) Matsuhisa M, Yamasaki Y, Emoto M, Shimabukuro M, Funahashi T, and Matsuzawa Y. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes research and clinical practice. (2007) 77: 151-4.
(21) Inoue M, Maehata E, Yano M, Taniyama M, and Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism. (2005) 54: 281-6.
(22) Hung AM and Ikizler TA, Factors determining insulin resistance in chronic hemodialysis patients, in Hemodialysis. 2011, Karger Publishers. p. 127-34.
(23) Hung AM, Sundell MB, Egbert P, Siew ED, Shintani A, Ellis CD, Bian A, and Ikizler TA. A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clinical Journal of the American Society of Nephrology. (2011) CJN. 08070910.
(24) Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, and Horikawa Y. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism. (2008) 57: 268-73.
(25) Finucane F, Luan J, Wareham N, Sharp S, O’Rahilly S, Balkau B, Flyvbjerg A, Walker M, Højlund K, and Nolan J. Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia. (2009) 52: 2345-9.
(26) Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, Kuzuya H, Shimatsu A, and Ogawa Y. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes care. (2004) 27: 2488-90.
(27) Makni E, Moalla W, Lac G, Aouichaoui C, Cannon D, Elloumi M, and Tabka Z. The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. in Annales d'endocrinologie. 2012: Elsevier.
(28) Frühbeck G, Catalán V, Rodríguez A, and Gómez-Ambrosi J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. (2018) 7: 57-62.
(29) Montazerifar F, Karajibani M, Keikhaie MA, Mohammadi M, Jouy SH, and Rezaie M. Serum Adiponectin and Vaspin levels in Abdominal Obesity and Type 2 Diabetes Mellitus. Iranian Journal of Diabetes & Obesity (IJDO). (2018) 10:
(30) Gijón-Conde T, Graciani A, Guallar-Castillón P, Aguilera MT, Rodríguez-Artalejo F, and Banegas JR. Leptin reference values and cutoffs for identifying cardiometabolic abnormalities in the Spanish population. Revista Española de Cardiología (English Edition). (2015) 68: 672-9.
(31) Bordelon P, Ghetu MV, and Langan R. Recognition and management of vitamin D deficiency. American family physician. (2009) 80: 841-6.
(32) Taheri E, Saedisomeolia A, Djalali M, Qorbani M, and Civi MM. The relationship between serum 25-hydroxy vitamin D concentration and obesity in type 2 diabetic patients and healthy subjects. Journal of Diabetes & Metabolic Disorders. (2012) 11: 16.
(33) Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, and Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clinical nutrition. (2013) 32: 970-5.
(34) Jorde R and Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. European journal of nutrition. (2009) 48: 349.
(35) Nagpal J, Pande J, and Bhartia A. A double‐blind, randomized, placebo‐controlled trial of the short‐term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle‐aged, centrally obese men. Diabetic Medicine. (2009) 26: 19-27.
(36) Patel P, Poretsky L, and Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: a pilot prospective randomized trial. Journal of diabetes. (2010) 2: 36-40.
(37) Heshmat R, Tabatabaei-Malazy O, Abbaszadeh-Ahranjani S, Shahbazi S, Khooshehchin G, Bandarian F, and Larijani B. Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial. DARU Journal of Pharmaceutical Sciences. (2012) 20: 10.
(38) Baziar N, DJafarian K, Shadman Z, Qorbani M, Khoshniat Nikoo M, and Razi F. EFFECT OF VITAMIN D SUPPLEMENTATION ON IMPROVING VITAMIN D LEVELS AND INSULIN RESISTANCE IN VITAMIN D INSUFFICIENT OR DEFFICIENT TYPE2 DIABETICS. Iranian Journal of Diabetes and Lipid Disorders. (2014) 13: 425-33.
(39) Jung UJ and Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International journal of molecular sciences. (2014) 15: 6184-223.
(40) Mantzoros CS, Li T, Manson JE, Meigs JB, and Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. (2005) 90: 4542-8.
(41) baba Ahmadi Rezaie H, Goodarzi Mt, kadkhodaie M, Haddadi nejad S, and navidi abbaspoor Aa. The correlation between adiponectin with blood lipids and body mass index in women with type 2 diabetes. Iranian South Medical Journal. (2007) 10: 40-5.
(42) Karastergiou K, Smith SR, Greenberg AS, and Fried SK. Sex differences in human adipose tissues–the biology of pear shape. Biology of sex differences. (2012) 3: 13.